OPVn
OPVn, also known as Oral Polio Vaccine n, is a live, attenuated vaccine used to prevent poliomyelitis, a viral disease that can cause paralysis. It is part of the global effort to eradicate polio, a disease that has affected millions of people worldwide. The vaccine is administered orally, typically through drops placed on the inside of the cheek, and is designed to stimulate the body's immune response to the poliovirus.
OPVn was developed as part of the ongoing research and improvement of the polio vaccine. It is
The vaccine is administered in a series of doses, usually starting with three doses given at two-month
OPVn is a key component of the World Health Organization's (WHO) global polio eradication initiative. The vaccine